Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Aug 16.
Published in final edited form as: AMA J Ethics. 2021 Feb 1;23(2):E97–108. doi: 10.1001/amajethics.2021.97

What Should Clinicians Do When A Patient’s Autonomy Undermines Her Being Treated Equitably?

Amy Scharf 1, Louis Voigt 2, Santosha Vardhana 3, Konstantina Matsoukas 4, Lisa M Wall 5, Maria Arevelo 6, Lisa C Diamond 7
PMCID: PMC8366686  NIHMSID: NIHMS1724075  PMID: 33635189

Abstract

Language and cultural barriers can impede communication between patients and clinicians, which exacerbate health inequity. Additional complications can arise when family members, intending to protect their loved ones, ask clinicians to lie or not disclose to patients their diagnoses, prognoses, or intervention options. Clinicians must express respect for patients’ and families’ cultural, religious, and social norms regarding health care decision making, but can also be ethically troubled some decisions effects on patients’ health outcomes. This article suggests strategies for clinicians trying to overcome linguistic and cultural barriers to equitable patient care.

Case

Mrs Z is a 70-year-old Pakistani widow with limited English language proficiency. She came to the United States, where her children live, to have masses in her neck and armpit evaluated. Physical examination and subsequent biopsies revealed an aggressive B-cell lymphoma, a hematologic malignancy uniformly fatal without chemotherapy. Mrs Z is staying with her eldest son (her health care agent) and daughter-in-law and granted them permission to access her health information via the hospital’s patient portal.

After accessing Mrs Z’s biopsy results, Mrs Z’s children told her the masses were not cancer. Her son then asked Mrs Z’s caregivers not to reveal to her that she has lymphoma. He explained his and his sibling’s intention to protect Mrs Z, strongly believing that she could neither emotionally cope with her diagnosis nor physically tolerate lymphoma treatment. Six years earlier, Mrs Z’s younger sister died from lymphoma, despite aggressive chemotherapy.

Mrs Z’s physicians, however, believed it was imperative that oncologists assess her case and develop an individualized treatment plan. Lymphomas, even those diagnosed within the same family, vary in prognoses and treatment options.1,2 They encouraged Mrs Z’s children that Mrs Z’s experience might not be at all like her sister’s. They explained that some lymphomas are indolent and require no or mild treatment, while others are aggressive and compel immediate attention, without which a patient could die within days.3

Mrs Z’s physicians also emphasized age as an important factor in predicting treatment response, so they suggested that discussions with Mrs Z should include risks and benefits of therapy.4,5 Lymphoma is mostly treated with cytotoxic agents, and older patients with comorbid conditions generally experience worse outcomes and side effects, such as myelosuppression, cardiac dysfunction, peripheral neuropathy, ileus, steroid-associated complications, and increased risk of treatment-related mortality.6,7

Mrs Z’s oncologist and nurse practitioner believed that Mrs Z’s decision-making capacity was intact, which means that she is her own decision-maker and that her son’s role as decision-maker only comes into play if she does not have capacity to make a specific decision at a specific point in time. They also clarified to her son that, with assistance from an interpreter, they could compassionately and thoroughly explain to her the lymphoma diagnosis, along with benefits and risks of treatment options. Mrs Z’s son declined both a follow-up appointment with the oncologist and the offer of an interpreter, however. The oncologist and nurse practitioner requested a clinical ethics consultation for guidance and wondered what to do next.

Commentry

Physicians in the United States treat patients from all over the world and have a fiduciary and ethical duty to treat them all equally. This responsibility includes providing them with clear and meaningful information and recommendations and ascertaining and honoring, to the best of their abilities, the health care choices of adult patients who possess decision-making capacity. Language or cultural barriers can impede communication between physicians and patients, which can adversely affect the physician-patient relationship, potentially resulting in inequities in health care delivery. Additional complications might arise when family members, with the intent of protecting their loved ones, ask physicians to lie or not disclose to patients their diagnoses, prognoses, or treatment options. While recognizing and respecting the importance of cultural, religious, and social norms in health care decision-making, physicians nevertheless may be concerned that well-intentioned family members are inappropriately interfering with, or even coopting, the self-determination of adult patients with decision-making capacity. Based on the preceding case, this paper aims to explore such morally challenging situations and present strategies for addressing linguistic and cultural differences with the goal of providing equitable, ethical, and clinically appropriate patient care.

Practical and Linguistic Considerations

In the United States, more than 25 million people (roughly 9% of the population) are considered as having limited English proficiency (LEP).8 From regulatory, clinical, and ethical standpoints, it is imperative that hospitals and other health care settings provide accommodations for patients with LEP, whose rights are guaranteed by multiple regulations, including (but not limited to) the Civil Rights Act of 1964,9 the Affordable Care Act,10 and the National Standards for Culturally and Linguistically Appropriate Services (CLAS).11 Studies have demonstrated that the use of professional interpreters improves the quality of care for patients with LEP, resulting in higher patient satisfaction,12 fewer errors in communication,13 reduced disparities in utilization of services,14 and improved clinical outcomes.15,16 Complementary studies have found that relying on nonprofessional interpreters can cause an increase in interpretation errors, such as misinterpretation of information and alteration of key patient details,17 which can potentially harm patients.16,18 Several studies support the idea that the use of interpreters is not only a quality imperative but also a patient safety imperative.16,1921

The gold standard for communication with patients with is matching them with clinicians who are truly fluent in their preferred languages.22 To assist partially fluent or nonfluent clinicians in communicating with patients,23,24 most hospitals offer language assistance services, including the next-best practice of in-person professional medical interpreters.25 Other interpretation services include the use of remote professional medical interpreters (via telephone or video links), ad-hoc bilingual clinicians, ad-hoc bilingual hospital employees26 (other than the treating physician), and bilingual family members. Bilingual family members’ serving as interpreters, except when explicitly requested by the patient, is not permitted under federal, state, and many hospitals’ policies.11 Under the Affordable Care Act, Section 1557, anyone functioning as an interpreter must undergo a language skills assessment and interpreter training.10 Table 1 highlights the advantages and disadvantages of various types of available language assistance.

Table 1.

Sources of Language Assistance for LEP Patientsa

Type and Description Advantages Disadvantages
Professional In-Person Medical Interpreter
(Highest-standard on-site medical interpretation service)
• Optimal medical and interpreter training
• National medical interpreter certification
• Adherence to professional oath and code of ethics
• Availability depends on location and time of day
• Limited language availability
Professional Telephonic Medical Interpreter
(Usually available through a landline, mobile phone, or dedicated device)
• Similar training, certification, and requirements as in-person interpreters
• Available 24/7
• Impersonal; interpreter cannot read body language or visual cues
• Potential technology problems and lags
• Difficult for patients with hearing or cognitive impairments
• or delirium
Professional Video Medical Interpreter
(Available through a video-capable device)
• Similar training, certification, and requirements as in-person interpreters
• More personal and better-equipped to read visual cues than telephonic services
• Limited availability, languages, and
• hours of operation
• Potential technology problems and lags
Bilingual Clinician
(Clinician who is fluent in the language of patient)
• Time-saving
• High level of comfort and familiarity
• Evidence of improved care and outcomes47
• Clinician’s language skills unproven
• Potential biases and role confusion
Ad-hoc or Dual-Role Interpreter
(Other hospital staff member who is available to assist when other interpreters are unavailable)
• Potentially time-saving
• Potentially more personal if preexisting relationship with patient exists
• Unfamiliarity with medical terminology may lead to errors.
• Proficiency in target language unproven
• Concerns about confidentiality, bias, omissions, and inappropriate editing
Bilingual Family Member or Friend
(Family member or friend of patient who self-reports bilingual skills)
• Time-saving, convenient
• High level of comfort and familiarity
• Same concerns as for ad-hoc or dual-role interpreters
• Potential role confusion
• May impede frank discussions between patient and physician
a

Adapted from American Medical Association,50 Hsieh E,51 National Council on Interpreting in Health Care.52

Relying on family members to serve as interpreters can present clinical and ethical pitfalls. As exemplified by this case, family members often assume the role of interpreter as a means of convenience and comfort during what can be a stressful clinical encounter. However, family members who are not familiar with medical terminology or whose English (or target language) skills are limited can inadvertently cause harm to patients through interpretation errors, misunderstandings, or omissions.27 Other subtler, yet still potentially harmful, risks include inappropriate editing or polishing of a patient’s information or an injection (intentionally or unintentionally) of bias into the interpretation. Moreover, some patients might be reluctant to discuss embarrassing or sensitive information in front of their relatives, potentially omitting vital clinical information or impairing an open patient-clinician relationship.18,28,29

Patient autonomy might also be compromised when family members serve as interpreters. The case of Mrs Z serves as an extreme example of a patient whose voice has been effectively silenced. Professional medical interpreters are better equipped to respect patient autonomy. They have no personal relationships with patients, which allows them to focus solely on their professional clinical responsibilities, and are well-trained in clinical terminology, hospital and governing rules regarding patient privacy (such as the Health Insurance Portability and Accountability Act), state and federal mandates, and their own code of ethics.30 In contrast, family members must play several difficult and emotionally charged roles with patients: they are caregivers, comforters, negotiators, conciliators, and logicians. Adding interpreter to the list of responsibilities increases their burdens and may detract from their ability to provide their loved ones with necessary emotional support.31

Cultural and Ethical Considerations

The case of Mrs Z also illuminates the ethical challenges that can arise in the context of cultural differences between physicians and patients and the importance of recognizing and upholding ethical principles of autonomy and relational autonomy, truth telling, and the right not to know.

Autonomy and relational autonomy.

The principle of autonomy obligates physicians to provide patients with clear and meaningful information about their condition and to recommend pertinent diagnostic and therapeutic options. Physicians must appraise the ability of adult patients to (a) deliberate upon or intellectualize the information they receive, (b) discriminate between the recommended treatment options, and (c) act intentionally, free from the controlling influence of others and in accordance with their own beliefs and values.3234 Physicians must also acknowledge that individuals’ identity, needs, interests, and autonomous preferences are also shaped by their relationships with others.35 Individuals exist in socially embedded networks and relationships through which they develop their individual sense of self, their preferences, and their life plans, along with their social sense of responsibility, stewardship, and interdependence.

This framework is often referred to as relational autonomy.35 In essence, it is an expression of patient autonomy that may be actualized through group decision making or even through ceding decision making to others. In Mrs Z’s case, social, familial, religious, and cultural influences might shape her autonomous decision to relinquish disclosure of medical information and treatment decisions to her son. However, physicians should not infer a patient’s preferences for disclosure in the cases of patients with LEP. They should approach patients with LEP with questions such as, “How would you like us to convey information—to you, your family, or both?” Or, “How have you made medical decisions in the past? How would you like to make them now?”

Truth telling and the right not to know.

Truth telling by health care professionals is a foundation of the bioethical principles of respect for autonomy, beneficence, justice. Patient autonomy is predicated on patients knowing and appreciating their medical status and treatment options; without this cognizance, they are at risk of harm. The right to one’s medical information can be interpreted as a basic human right, as exemplified by the 1997 European Convention on Human Rights and Biomedicine: “Everyone is entitled to know any information collected about his or her health.”36

As with all bioethical principles, however, truth telling must be placed in context. Respecting patient autonomy does not imply a “one-size-fits-all” approach to truth telling or require “truth dumping”—the disclosure of all aspects of a disease or treatments without regard for a patient’s needs or desire for information.37 Disclosure must take into consideration the patient’s stated preferences for receiving information, making decisions, and family involvement.3740 The right not to know one’s medical diagnosis, prognosis, or treatment options is also endorsed by the European Convention on Human Rights and Biomedicine: “the wishes of individuals not to be so informed [about their health] shall be observed.” 36Although some clinicians might interpret this preference as Panglossian, counterproductive, or even harmful, they must respect that sometimes, the autonomous choice of an adult patient with decision-making capacity is to not know or to delegate truth telling to a surrogate. Faced with the prospect of an incurable disease, some individuals might consider the burden of knowledge to be unbearable; disclosure can lead to severe depression and negatively affect family and social life.41

Cultural norms and truth telling: potential ethical pitfalls.

Several published accounts address cultural norms and the role of family in receiving, conveying, and deciding on disclosure of medical information and interventions.38,42,43 A predominant theme is that disclosure to patients alone, without family present, is a characteristically American or Western or allopathic phenomenon and that in many countries—both developed and less economically developed—the family is the primary recipient of a diagnosis; the question is often whether the patient should be told in addition to the family.4447 Although clinicians should recognize the religious, cultural, and social contexts of their patients and families, they should not assume that these contexts unwaveringly dictate their health care choices. Patients’ preferences are individualistic, and physicians must treat them as such. Several studies have found that while many patients recognize the inherent legitimacy and importance of nondisclosure in their culture, they personally wish to be involved in their own health care decisions.38,42,45,48 One must not automatically infer that Mrs Z’s age, culture, and religion dictate her health care preferences. By the same token, physicians and other health care professionals should not try to impose their own culturally based disclosure preferences on the patient.

Recommendations

The following are suggestions for engaging patients and family members in productive, open dialogues, which may serve to improve patient care and reduce health disparities that can occur in the presence of linguistic or cultural differences (see Table 2).49

Table 2.

Responses to a Family’s Request to Hide the Truth from a Patienta

Strategy Example
Do Not Overreact  • Resist the impulse to say: “This is not how we do things here—we must tell your mother her diagnosis.”
Listen
 • Try to learn whether the family’s request is a manifestation of their own fears or distress.
 • Try to learn whether the request is prompted by the family feeling responsible for shouldering the burdens of worry, despair, or responsibility for difficult decisions.
Acknowledge  • I see how much you and your family love your mother.
 • I appreciate your wanting to shield your mother from harm.
Empathize  • I share the same goal of wanting to keep your mother from harm.
 • I want to do everything possible for your mother’s well-being.
Relate  • Truthfulness is vital to me as both a physician and a human.
Offer Suggestions  • Promote an atmosphere of open dialogue, which will enable the medical team to better serve the patient.
 • When eliciting the patient’s disclosure preferences, remember that the diagnosis does not need to be revealed.
 • Consider professional medical interpreters, which are beneficial for both the patient and the family.
 • Offer additional support services, such as chaplaincy, social work, and patient representative, that are available to help both the patient and the family cope during this stressful time.
 • Seek to understand the level of involvement the patient would like to have in making decisions or whether the patient wants to defer to the family.
a

Adapted from Hallenbeck J, Arnold R.3

Engage patients about their preferences as early as possible.

Physicians should engage patients in open, well-documented dialogues about their preferences regarding disclosure of diagnoses and other medical information as early as possible in the patient-clinician relationship, preferably with a professional interpreter present. Doing so will promote equity; enable culturally appropriate, patient-centered care; and potentially avoid future requests for nondisclosure by family members. Unfortunately, time and logistical constraints might impede a physician from securing a medical interpreter for these preemptive discussions. Ideally, knowing a patient’s LEP status in advance might help physicians and institutions better prepare for consultations.

Proactively suggest engaging a medical interpreter.

At the beginning of the consultation, physicians should inform patients and families about the availability of professional medical interpreters as essential resources in the delivery of high-quality, equitable, and patient- and family-centered care. They should stress that relying on professional interpreters does not preclude family members from participating in encounters, nor is it a sign of the family’s weakness or incompetency. Rather, it is a means of ensuring the best possible care. Physicians might nevertheless encounter resistance from families, who might consider interpreter services—particularly those that must be accessed remotely via telephone, video, or other platforms—to be too impersonal, unsatisfying, or complicated.

Engage reluctant or contentious family members in a calm, productive manner, utilizing ethics consultations or other supportive services.

Preemptive discussions are not always feasible, and often, as with Mrs Z, circumstances make it difficult to ascertain the patient’s preferences. In these circumstances, physicians should work to engage the family in a calm, productive dialogue, engaging ethics consultants or other supportive services, such as social work or chaplaincy.

Do not overreact to family requests for lying or nondisclosure.

It is critical to resist the impulse to respond to requests for nondisclosure with: “Absolutely not. This is not how we do things here.” The family might interpret this as a criticism, resulting in an escalation of the conflict38 or a total cessation of communication—both of which could ultimately cause harm to the patient.

Listen.

Try to ascertain the family’s concerns and reasons behind their request for nondisclosure. The request might be a reaction to the family’s fears and distress at its loved one’s diagnosis or a manifestation of a sense of duty to relieve the patient of the burden of worry, loss of hope, and responsibility for difficult decisions.38

Acknowledge, empathize, and relate.

Compassionate and empathetic responses, such as “I appreciate your wanting to protect your mother from harm. I share that goal,”38 will go a long way to convey that you have the patient’s best interest at heart. Furthermore, explaining how truthfulness is vital to you as a human being might allow the family to relate to you as a person, not just as a physician.

Offer other suggestions.

Prevent framing the response to the request for nondisclosure as a zero-sum argument.38 Instead, explain how the medical team will be able to better serve the patient in an atmosphere of open dialogue. Discuss strategies that allow patients to voice their preferences regarding disclosure and decision making and explain that eliciting their preferences can be done respectfully, without revealing the diagnosis. Offer explanations of how medical interpreters improve health equity and benefit both the patient and the family by removing burdensome interpreter responsibilities and allowing the family to focus on emotionally supporting the patient. Finally, discuss additional support services, such as chaplaincy, patient representatives, and social work, that are available to help the patient and family during this stressful time.

Despite physicians’ best efforts to utilize these strategies in a compassionate and respectful manner to form therapeutic alliances with families, they can still be unsuccessful. Family members might remain adamant that the patient not be told her diagnosis, maintaining that they, as her loved ones and penultimate support system, know what is in her best interest. Physicians might continue to grapple with how, under such circumstances, to deliver just and equitable care for the patient in a clinically and ethically appropriate manner. Hospital ethics committees and additional support services might be helpful in this endeavor.

Conclusion

Linguistic or cultural differences should never prevent patients from receiving equitable and clinically and ethically appropriate health care. Physicians have a moral and fiduciary responsibility to attempt to address these potential impediments to ascertain how patients prefer to receive information and to make decisions about their care. Toward this end, physicians should employ available resources, such as professional medical interpreters and other institutional services, while maintaining an awareness of, and respect for, patients’ and families’ unique cultural or social dynamics.

Biographies

Amy Scharf, MS, is bioethicist and member of the Ethics Commitee at Memorial Sloan Kettering Cancer Center. She holds a Masters of Science in Bioethics from Columbia University.

Louis Voigt, MD, is an Associate Professor of Clinical Medicine and Anesthesiology at the Weill Cornell Medical College, an Associate Attending Physician in the Department of Medicine and in the Department of Anesthesiology, Pain and Critical Care Medicine, and the Ethics Committee Chair at Memorial Sloan Kettering Cancer Center. He holds certification by the American Board of Internal Medicine (ABIM) in Internal Medicine, Pulmonary Disease, Critical Care Medicine, and Hospice and Palliative Medicine. Current research interests include ethical issues surrounding decision-making processes in cancer care and research, end of life processes in oncology practice, and cognitive and physical complications and sequelae in critically ill patients with cancer.

Santosha Vardhana, MD, PhD, is a physician-scientist and medical oncologist at Memorial Sloan Kettering Cancer Center. His clinical care is focused on inpatient management of lymphoma, and his research explores methods to augment the immune system for the treatment of cancer.

Konstantina Matsoukas, MLIS, is a Research Informationist at Memorial Sloan Kettering Cancer Center’s Medical Library. She also serves as a member of MSK’s multidisciplinary Ethics Committee.

Lisa Wall, PhD, RN, CNS, AOCNS is a Clinical Nurse Specialist and Ethics Consultant at Memorial Sloan Kettering Cancer Center. She holds two advanced degrees in nursing and is certified as an Advanced Oncology Clinical Nurse Specialist (AOCNS) and Healthcare Ethics Consultant (HEC-C). In both of her roles, she has participated in many collaborative initiatives across the care continuum to enhance the patient experience.

Maria Arevalo, RN, BSN, OCN is a clinical nurse at Memorial Sloan Kettering Cancer Center.

Lisa C. Diamond, MD, MPH is a member of the Memorial Sloan Kettering Cancer Center research faculty of the Immigrant Health and Cancer Disparities Service, which facilitates linguistically and culturally sensitive health care services for newcomer populations through research, education, training, program development, policy, and advocacy. Her research focuses on understanding how clinician non-English language proficiency affects the quality of care delivered to patients with limited English proficiency (LEP).

Contributor Information

Amy Scharf, bioethicist and member of the Ethics Commitee at Memorial Sloan Kettering Cancer Center.

Louis Voigt, Associate Professor of Clinical Medicine and Anesthesiology at the Weill Cornell Medical College, an Associate Attending Physician in the Department of Medicine and in the Department of Anesthesiology, Pain and Critical Care Medicine, and the Ethics Committee Chair at Memorial Sloan Kettering Cancer Center.

Santosha Vardhana, physician-scientist and medical oncologist at Memorial Sloan Kettering Cancer Center.

Konstantina Matsoukas, Research Informationist at Memorial Sloan Kettering Cancer Center’s Medical Library.

Lisa M. Wall, Clinical Nurse Specialist and Ethics Consultant at Memorial Sloan Kettering Cancer Center.

Maria Arevelo, clinical nurse at Memorial Sloan Kettering Cancer Center.

Lisa C. Diamond, member of the Memorial Sloan Kettering Cancer Center research faculty of the Immigrant Health and Cancer Disparities Service.

References

  • 1.Fernandez V, Salamero O, Espinet B, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010;70(4):1408–1418. [DOI] [PubMed] [Google Scholar]
  • 2.Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(25):1937–1947. [DOI] [PubMed] [Google Scholar]
  • 3.Horwitz SM, Zelenetz AD, Gordon LI, et al. NCCN Guidelines Insights: Non-Hodgkin’s Lymphomas, Version 3.2016. J Natl Compr Canc Netw. 2016;14(9):1067–1079. [DOI] [PubMed] [Google Scholar]
  • 4.Hedstrom G, Hagberg O, Jerkeman M, Enblad G. The impact of age on survival of diffuse large B-cell lymphoma - a population-based study. Acta Oncol. 2015;54(6):916–923. [DOI] [PubMed] [Google Scholar]
  • 5.Liu H, Zhang CL, Feng R, Li JT, Tian Y, Wang T. Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B-Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment. Oncologist. 2018;23(6):722–729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Delarue R, Tilly H, Mounier N, et al. Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03–6B study): a randomised phase 3 trial. Lancet Oncol. 2013;14(6):525–533. [DOI] [PubMed] [Google Scholar]
  • 7.Pfreundschuh M, Schubert J, Ziepert M, et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol. 2008;9(2):105–116. [DOI] [PubMed] [Google Scholar]
  • 8.Zong J, Batalova J, Migration Policy Institute. The Limited English Proficient Population in the United States. 2015https://www.migrationpolicy.org/article/limited-english-proficient-population-united-states.
  • 9.U. S. Department of Justice. Title VI of the Civil Rights Act of 1964. http://https://www.justice.gov/crt/fcs/TitleVI: Civil Rights Division, Federal Coordination and Compliance Section;1964. [Google Scholar]
  • 10.Patient Protection and Affordable Care Act of 2010, Pub L No. 111-148, 124 Stat 119..
  • 11.U.S. Department of Health and Human Services. National Standards for Culturally and Linguistically Appropriate Services (CLAS) in Health and Health Care. https://thinkculturalhealth.hhs.gov/clas/: Office of Minority Health;2013. [Google Scholar]
  • 12.Baker DW, Hayes R, Fortier JP. Interpreter use and satisfaction with interpersonal aspects of care for Spanish-speaking patients. Med Care. 1998;36(10):1461–1470. [DOI] [PubMed] [Google Scholar]
  • 13.Flores G, Laws MB, Mayo SJ, et al. Errors in medical interpretation and their potential clinical consequences in pediatric encounters. Pediatrics. 2003;111(1):6–14. [DOI] [PubMed] [Google Scholar]
  • 14.Jacobs EA, Lauderdale DS, Meltzer D, Shorey JM, Levinson W, Thisted RA. Impact of interpreter services on delivery of health care to limited-English-proficient patients. J Gen Intern Med. 2001;16(7):468–474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Flores G The impact of medical interpreter services on the quality of health care: a systematic review. Med Care Res Rev. 2005;62(3):255–299. [DOI] [PubMed] [Google Scholar]
  • 16.Karliner LS, Jacobs EA, Chen AH, Mutha S. Do professional interpreters improve clinical care for patients with limited English proficiency? A systematic review of the literature. Health Serv Res. 2007;42(2):727–754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lopez L, Rodriguez F, Huerta D, Soukup J, Hicks L. Use of interpreters by physicians for hospitalized limited English proficient patients and its impact on patient outcomes. J Gen Intern Med. 2015;30(6):783–789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gany F, Kapelusznik L, Prakash K, et al. The impact of medical interpretation method on time and errors. J Gen Intern Med. 2007;22Suppl 2(Suppl 2):319–323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Cohen AL, Rivara F, Marcuse EK, McPhillips H, Davis R. Are language barriers associated with serious medical events in hospitalized pediatric patients? Pediatrics. 2005;116(3):575–579. [DOI] [PubMed] [Google Scholar]
  • 20.David RA, Rhee M. The impact of language as a barrier to effective health care in an underserved urban Hispanic community. Mt Sinai J Med. 1998;65(5-6):393–397. [PubMed] [Google Scholar]
  • 21.Institute of Medicine Committee on Quality of Health Care in America (National Academy of Sciences). Crossing the Quality Chasm: A New Health System for the 21st Century. Washington (DC): National Academies Press (US); 2001. [Google Scholar]
  • 22.Diamond L, Izquierdo K, Canfield D, Matsoukas K, Gany F. A Systematic Review of the Impact of Patient-Physician Non-English Language Concordance on Quality of Care and Outcomes. J Gen Intern Med. 2019;34(8):1591–1606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Diamond L, Chung S, Ferguson W, Gonzalez J, Jacobs EA, Gany F. Relationship between self-assessed and tested non-English-language proficiency among primary care providers. Med Care. 2014;52(5):435–438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Diamond LC, Tuot DS, Karliner LS. The use of Spanish language skills by physicians and nurses: policy implications for teaching and testing. J Gen Intern Med. 2012;27(1):117–123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Diamond LC, Wilson-Stronks A, Jacobs EA. Do hospitals measure up to the national culturally and linguistically appropriate services standards? Med Care. 2010;48(12):1080–1087. [DOI] [PubMed] [Google Scholar]
  • 26.Aitken G Medical Students as Certified Interpreters. AMA J Ethics. 2019;21(3):E232–238. [DOI] [PubMed] [Google Scholar]
  • 27.Vandervort EB, Melkus GD. Linguistic services in ambulatory clinics. J Transcult Nurs. 2003;14(4):358–366. [DOI] [PubMed] [Google Scholar]
  • 28.Ho A Using family members as interpreters in the clinical setting. J Clin Ethics. 2008;19(3):223–233. [PubMed] [Google Scholar]
  • 29.Labaf A, Shahvaraninasab A, Baradaran H, Seyedhosseini J, Jahanshir A. The Effect of Language Barrier and Non-professional Interpreters on the Accuracy of Patient-physician Communication in Emergency Department. Adv J Emerg Med. 2019;3(4):e38–e38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.National Council on Interpreting in Health Care. A National Code of Ethics For Interpreters in Health Care, NCIHC Working Papers Series, July2004. https://www.ncihc.org/assets/documents/publications/NCIHC%20National%20Code%20of%20Ethics.pdf.
  • 31.Diamond LC, Schenker Y, Curry L, Bradley EH, Fernandez A. Getting by: underuse of interpreters by resident physicians. J Gen Intern Med. 2009;24(2):256–262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Appelbaum PS. Clinical practice. Assessment of patients’ competence to consent to treatment. N Engl J Med. 2007;357(18):1834–1840. [DOI] [PubMed] [Google Scholar]
  • 33.Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 7th ed.New York, NY: Oxford University Press; 2013. [Google Scholar]
  • 34.Latcha S, Lineberry C, Lendvai N, et al. “Please Keep Mom Alive One More Day”-Clashing Directives of a Dying Patient and Her Surrogate. J Pain Symptom Manage. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Dove ES, Kelly SE, Lucivero F, Machirori M, Dheensa S, Prainsack B. Beyond individualism: Is there a place for relational autonomy in clinical practice and research? Clin Ethics. 2017;12(3):150–165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Council of Europe. Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. Article 10.2. European Treaty Series - No. 164.https://www.humanrights.ch/en/standards/ce-treaties/biomedicine/; 1997.
  • 37.McCabe MS, Wood WA, Goldberg RM. When the family requests withholding the diagnosis: who owns the truth? J Oncol Pract. 2010;6(2):94–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hallenbeck J, Arnold R. A request for nondisclosure: don’t tell mother. J Clin Oncol. 2007;25(31):5030–5034. [DOI] [PubMed] [Google Scholar]
  • 39.Jotkowitz A, Glick S, Gezundheit B. Truth-telling in a culturally diverse world. Cancer Invest. 2006;24(8):786–789. [DOI] [PubMed] [Google Scholar]
  • 40.Jotkowitz AB, Glick S, Porath A. A physician charter on medical professionalism: a challenge for medical education. Eur J Intern Med. 2004;15(1):5–9. [DOI] [PubMed] [Google Scholar]
  • 41.Andorno R The right not to know: an autonomy based approach. J Med Ethics. 2004;30(5):435–439; discussion 439-440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Butow PN, Tattersall MH, Goldstein D. Communication with cancer patients in culturally diverse societies. Ann N Y Acad Sci. 1997;809:317–329. [DOI] [PubMed] [Google Scholar]
  • 43.Gostin LO. Informed consent, cultural sensitivity, and respect for persons. Jama. 1995;274(10):844–845. [PubMed] [Google Scholar]
  • 44.Li S, Chou JL. Communication with the cancer patient in China. Ann N Y Acad Sci. 1997;809:243–248. [DOI] [PubMed] [Google Scholar]
  • 45.Mitsuya H Telling the truth to cancer patients and patients with HIV-1 infection in Japan. Ann N Y Acad Sci. 1997;809:279–289. [DOI] [PubMed] [Google Scholar]
  • 46.Mystakidou K, Liossi C, Vlachos L, Papadimitriou J. Disclosure of diagnostic information to cancer patients in Greece. Palliat Med. 1996;10(3):195–200. [DOI] [PubMed] [Google Scholar]
  • 47.Uchitomi Y, Yamawaki S. Truth-telling practice in cancer care in Japan. Ann N Y Acad Sci. 1997;809:290–299. [DOI] [PubMed] [Google Scholar]
  • 48.Bruera E, Neumann CM, Mazzocato C, Stiefel F, Sala R. Attitudes and beliefs of palliative care physicians regarding communication with terminally ill cancer patients. Palliat Med. 2000;14(4):287–298. [DOI] [PubMed] [Google Scholar]
  • 49.Ridgeway JL, Njeru JW, Breitkopf CR, et al. Closing the Gap: Participatory Formative Evaluation to Reduce Cancer Screening Disparities among Patients with Limited English Proficiency. J Cancer Educ. 2020. [DOI] [PubMed] [Google Scholar]
  • 50.American Medical Association. Table 1. Types of Interpreters Used and Quality of Provider-Patient Communication In. Office Guide to Communicating with Limited English Proficient Patients. 2nd ed; 2013:4. [Google Scholar]
  • 51.Hsieh E Understanding medical interpreters: Reconceptualizing bilingual health communication. Health Commun. 2006;20(2):177–186. [DOI] [PubMed] [Google Scholar]
  • 52.National Council on Interpreting in Health Care. FAQ - Translators and Interpreters. NCIHC: Washington, DC: https://www.ncihc.org/faq-for-translators-and-interpreters.Accessed March 31, 2020. [Google Scholar]

RESOURCES